3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow RVT-1502: new trials by email Literature Review of RVT-1502 trials Research Report on RVT-1502
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Comparison Study of the Bioavailability of a Capsule Formulation of LGD-6972 to an Oral Solution Formulation LGD-6972 Solution, LGD-6972 Capsules - Type 2 Diabetes Mellitus (T2DM) | Phase 1 | Completed | Ligand Pharmaceuticals | 12 | 2016-02-01 | 2016-05-18 |
| Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus LGD-6972, Placebo (Captisol ®) - Type 2 Diabetes Mellitus | Phase 1 | Completed | Ligand Pharmaceuticals | 48 | 2014-10-01 | 2015-06-11 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus LGD-6972, Placebo (Captisol®) - Type 2 Diabetes Mellitus | Phase 1 | Completed | Ligand Pharmaceuticals | 56 | 2013-11-01 | 2014-09-25 |
United States (3)
Douglas K Logan, M.D. (1) · Keith Marschke, Ph.D. (1) · Lukasz Biernat, M.D. (1)